"You can find confined and really limited permissions for certain pharmaceutical providers to make use of that material for investigation uses and for pretty specific narrowly prescribed clinical reasons," he discussed.“Damage reduction is really a critically important and mainstream subject, and we're staying at the forefront of drug restriction